Press Releases

DURHAM, N.C., Aug. 6, 2019 /PRNewswire/ -- Emergo Therapeutics has successfully completed their Phase 2a trial for their novel candidate norketotifen (NKT).  The trial is yet another step forward in addressing the symptoms of the flu and flu-like illness. The unique Phase 2a trial focused on using the immunomodulatory properties of NKT to treat sympto

PHILADELPHIA, Aug. 6, 2019 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX, "the Company") today announced that Michael F. Cola, President and Chief Executive Officer, will present at the 2019 Wedbush PacGrow Healthcare Conference on Tuesday, August 13, 2019 at 1:20 p.m. EDT

BOSTON, Aug. 6, 2019 /PRNewswire/ -- COTA, Inc., a healthcare technology company that uses real-world evidence (RWE) to bring clarity to cancer care, has announced its participation in a pilot program led by Friends of Cancer Research (Friends) focused on advancing the understanding and applications of RWE in oncology research

ST. LOUIS, Aug. 6, 2019 /PRNewswire/ -- Bayer has awarded

PRINCETON, N.J., Aug. 6, 2019 /PRNewswire/ -- healtheo360, an online community of patients and caregivers with a network of over 30 million, has announced that Greg Byam has joined the company as Vice President, Business Development.With over 20 years of experience, Greg has devoted his career to leveraging innovative digital t

WESTBURY, N.Y., Aug. 6, 2019 /PRNewswire/ -- BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA. This acquisition will expand BioIVT's disease-sta

MCHENRY, Ill., Aug. 6, 2019 /PRNewswire/ -- Today, Medela LLC today announced its support of Breastfeeding: Uncovered, a partnership between Medela and

Dr. Alan Korman, renowned for his work leading to the development the first approved checkpoint inhibitor cancer therapies, joins Dragonfly's scientific team. WALTHAM, Mass., Aug. 6, 2019 /PRNewswire/ -- Dragonfly Therapeutics, Inc. ("Dragonfly") today announced the addition of world-leading cancer immunotherapy pioneer

ANAHEIM, Calif., Aug. 6, 2019 /PRNewswire/ -- AACC 2019 – New blood tests may help healthcare providers identify if patients are sensitized to up to 11 different molecular allergen component proteins found in dogs, cats, or horses. The assays analyze sensitivity to specific proteins found in the skin, fur and saliva of these animals.ImmunoCAP Alle

ANAHEIM, Calif., Aug. 6, 2019 /PRNewswire/ -- AACC 2019 – Thermo Fisher Scientific has expanded its portfolio of analytical instruments for clinical diagnostic laboratories with the addition of three systems now listed as Class I medical devices with the United States Food and Drug Administration (U.S. FDA). The portfolio enables clinical diagnostic labo